1. Home
  2. LICN vs INDP Comparison

LICN vs INDP Comparison

Compare LICN & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LICN
  • INDP
  • Stock Information
  • Founded
  • LICN 2004
  • INDP 2000
  • Country
  • LICN China
  • INDP United States
  • Employees
  • LICN N/A
  • INDP N/A
  • Industry
  • LICN
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LICN
  • INDP Health Care
  • Exchange
  • LICN Nasdaq
  • INDP Nasdaq
  • Market Cap
  • LICN 3.8M
  • INDP 4.0M
  • IPO Year
  • LICN 2023
  • INDP N/A
  • Fundamental
  • Price
  • LICN $3.85
  • INDP $3.63
  • Analyst Decision
  • LICN
  • INDP Strong Buy
  • Analyst Count
  • LICN 0
  • INDP 2
  • Target Price
  • LICN N/A
  • INDP $238.00
  • AVG Volume (30 Days)
  • LICN 20.1K
  • INDP 574.0K
  • Earning Date
  • LICN 01-01-0001
  • INDP 11-11-2025
  • Dividend Yield
  • LICN N/A
  • INDP N/A
  • EPS Growth
  • LICN N/A
  • INDP N/A
  • EPS
  • LICN N/A
  • INDP N/A
  • Revenue
  • LICN $37,641,000.00
  • INDP N/A
  • Revenue This Year
  • LICN N/A
  • INDP N/A
  • Revenue Next Year
  • LICN N/A
  • INDP N/A
  • P/E Ratio
  • LICN N/A
  • INDP N/A
  • Revenue Growth
  • LICN N/A
  • INDP N/A
  • 52 Week Low
  • LICN $2.60
  • INDP $2.22
  • 52 Week High
  • LICN $462.00
  • INDP $47.60
  • Technical
  • Relative Strength Index (RSI)
  • LICN 35.90
  • INDP 47.48
  • Support Level
  • LICN $3.75
  • INDP $3.41
  • Resistance Level
  • LICN $4.09
  • INDP $4.00
  • Average True Range (ATR)
  • LICN 0.28
  • INDP 0.63
  • MACD
  • LICN -0.07
  • INDP 0.04
  • Stochastic Oscillator
  • LICN 23.08
  • INDP 32.19

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: